Kinetic and Structural Characterization of a Flavin-Dependent Putrescine N-Hydroxylase from Acinetobacter baumannii

Noah S Lyons1, Alexandra N Bogner2, John J Tanner2,3

  • 1Department of Biochemistry and Center for Drug Discovery, Virginia Tech, Blacksburg, Virginia 24061, United States.

Biochemistry
|October 31, 2022
PubMed

Insights

This study characterizes FbsI, an enzyme crucial for Acinetobacter baumannii siderophore biosynthesis. Understanding FbsI

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • Multidrug-resistant Acinetobacter baumannii poses a significant threat, necessitating novel therapeutic strategies.
  • Targeting bacterial iron acquisition, specifically siderophore biosynthesis, is a promising avenue for new antibiotics.
  • Fimsbactin A is a key siderophore produced by A. baumannii.

Purpose of the Study:

  • To investigate the enzyme FbsI, an N-hydroxylating monooxygenase essential for fimsbactin A biosynthesis in A. baumannii.
  • To elucidate the biochemical and structural properties of FbsI.
  • To propose a catalytic mechanism for FbsI.

Main Methods:

  • Biochemical characterization including steady-state and transient-state kinetics.
  • Spectroscopic analysis, X-ray crystallography, and small-angle X-ray scattering (SAXS).
  • Computational modeling for substrate docking.

Main Results:

  • FbsI catalyzes the N-hydroxylation of putrescine and cadaverine, with a preference for putrescine as the in vivo substrate.
  • FbsI utilizes both NADPH and NADH as cofactors, preferring NADPH.
  • The crystal structure reveals FbsI as a Class B flavin-dependent monooxygenase, forming a tetramer in solution, structurally similar to other siderophore biosynthetic enzymes.

Conclusions:

  • FbsI is a tetrameric N-hydroxylating monooxygenase critical for A. baumannii siderophore production.
  • Structural and kinetic data provide insights into FbsI's substrate specificity and catalytic mechanism.
  • FbsI represents a potential drug target for combating multidrug-resistant A. baumannii infections.